Is SVB Financial (SIVB) A Great Investment Pick? – Yahoo Finance
Harding Loevner, an investment management firm, published its “World Equity Fund” second-quarter 2021 investor letter – a copy of which can be downloaded here. A return of 2.73% was recorded by the fund for the Q2 of 2021, below the 5.04% return of the MSCI World Index, and the 4.68% return of the MSCI All Country World Index for the same period. You can take a look at the fund’s top 5 holdings to have an idea about their top bets for 2021.
In the Q2 2021 investor letter of Harding Loevner, the fund mentioned SVB Financial Group (NASDAQ: SIVB) and discussed its stance on the firm. SVB Financial Group is a Santa Clara, California-based commercial banking company with a $38.9 billion market capitalization. SIVB delivered a 71.35% return since the beginning of the year, while its 12-month returns are up by 170.52%. The stock closed at $664.53 per share on October 1, 2021.
Here is what Harding Loevner has to say about SVB Financial Group in its Q2 2021 investor letter:
"Over the past year, the attractive valuation of high-quality companies in out-of-favor sectors has figured into our increased holdings of Energy and Financials. More recently, while we continue to be overweight the Financial sector, we have shifted the composition away from a group of banks with operations in struggling emerging economies in favor of enlarged holdings of two US banks (one of which is) SVB Financial Group. Both cater to lucrative niche markets and prioritize impeccable service as a means to grow through referrals from their affluent and contented clientele."
Based on our calculations, SVB Financial Group (NASDAQ: SIVB) was not able to clinch a spot in our list of the 30 Most Popular Stocks Among Hedge Funds. SIVB was in 49 hedge fund portfolios at the end of the first half of 2021. SVB Financial Group (NASDAQ: SIVB) delivered a 17.57% return in the past 3 months.
Hedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the S&P 500 ETFs by 115 percentage points since March 2017 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017. Interestingly the margin of underperformance of these stocks has been increasing in recent years. Investors who are long the market and short these stocks would have returned more than 27% annually between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter.
At Insider Monkey, we scour multiple sources to uncover the next great investment idea. For example, artificial intelligence is one of the fastest-growing industries right now, so we are checking out stock pitches like this emerging AI stock. We go through lists like the 10 best hydrogen fuel cell stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our homepage.
Disclosure: None. This article is originally published at Insider Monkey.
Related Quotes
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed those firms’ equity portfolios as of June 30th. The results of that effort will be put on display in this article, as […]
ClearBridge Investments, an investment management firm, published its “Small Cap Growth Strategy ” second quarter 2021 investor letter – a copy of which can be downloaded here. During the second quarter, the ClearBridge Small Cap Growth Strategy outperformed its Russell 2000 Growth benchmark. On an absolute basis, the Strategy had gains across eight of the 10 […]
NEED TO KNOW A risk-off Monday is brewing to start the week, with stock futures lower and the 10-year yield edging back toward 1.5%. There’s a lot for investors to think about, such as the start of earnings season that’s just about a week away, as some analysts look under the hood of the third quarter and don’t like what they see.
One EV maker taking a hit is growing Chinese EV company Nio (NYSE: NIO). As of 11 a.m. EDT today, Nio shares were down 5.3%, just off the lows of the morning. Nio released its September and third-quarter 2021 EV delivery data on Friday, and its quarterly deliveries exceeded the internal guidance that it had revised lower on Sept. 1 due to supply chain constraints.
U.S. stocks already are having a rough October — two trading days in. October is the most volatile month for stocks — and when stocks suffered their two worst crashes in U.S. market history. There aren’t many investors in the market today who remember the trauma of Black Monday.
In my view, it's a lot easier to be patient with your stocks when they're strong performers right out of the gate as a result of an effective business model and firm fundamentals. Instead, check the business model and fundamentals, if those are solid, your underperforming new stock could be worth the wait with time. The two healthcare companies I'll be discussing today will probably continue to grow steadily over the next decade, just as they have in recent times.
Xenon Pharmaceuticals (NASDAQ: XENE), a clinical-stage biotech, is having a superb showing in pre-market trading Monday morning. The biotech's shares, in fact, jumped by as much as 98%, on extremely heavy volume, before 8 a.m. today. Ahead of the opening bell, Xenon announced positive mid-stage trial results for XEN1101 as a potential treatment for adult patients with focal epilepsy.
Peak Fintech Group Inc. (CSE: PKK) ("Peak" or the "Company"), an innovative Fintech service provider and manager of the Cubeler Business Hub, today addressed a baseless and irresponsible report produced by Grizzly Research (https://grizzlyreports.com/Research/PKK.pdf) in which Grizzly Research alleges that the Company has misappropriated millions in funds. The report goes on to make several defamatory claims about the Company and some of its executives, which are nothing more than lies and fabri
Shares of Moderna (NASDAQ: MRNA) are sliding 5.9% lower as of 11:49 a.m. EDT on Monday. This drop appears to be a continuation of the sharp decline that began last week after Merck (NYSE: MRK) and Ridgeback Biotherapeutics announced positive results from a late-stage study of COVID-19 pill molnupiravir. Other vaccine stocks also are continuing to fall in response to Merck's good news.
These innovative stocks have been beaten down recently, but they could make patient investors a lot richer by the turn of the decade.
October is sometimes a scary month for investors. But you don't have anything to be afraid about buying these stocks.
Hut 8 Mining Corp. (NASDAQ: HUT) (TSX: HUT) ("Hut 8" or "the Company"), one of North America's largest, innovation-focused digital asset mining pioneers, supporting open and decentralized systems since 2018, is pleased to provide the following corporate update.
China Evergrande Group (OTC: EGRN.F) is in a bit of a bind. At last report, the Chinese property giant had missed the deadline for two separate interest payments to foreign bondholders — who are starting to look like foreign bagholders, because Evergrande had no trouble finding the money to pay interest on a domestic debt. As The Wall Street Journal reported this morning, Evergrande's property management business, Evergrande Property Services Group, has advised that it is preparing to report "inside information and a possible general offer for the shares of the company."
Facebook goes down for thousands of users across the globe.
Last week, all three major U.S. indices took a hit, though the tech-heavy Nasdaq Composite fell further than the S&P 500 or the Dow Jones Industrial Average. For instance, Fastly (NYSE: FSLY) stock is now down about 70% from its all-time high. Its edge cloud platform accelerates and secures the delivery of content (e.g.
In this article we will take a look at whether hedge funds think Devon Energy Corporation (NYSE:DVN) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, unconventional data sources, expert networks, and get tips […]
We looked at S&P 500 stocks that tumbled more than 10%, and screened for companies that have less debt, strong earnings outlooks, and high profits.
II-VI (NASDAQ:IIVI) has had a rough three months with its share price down 17%. However, the company's fundamentals…
The time to buy airline stock is now, argues Morgan Stanley.
Tesla is growing while auto production around the globe plummets. The EV pioneer is, apparently, beating other auto makers to chips. How come?
